Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
2023-05-25 19:36:30 ET Summary It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS could generate sales of $6.3 billion by 2030. Roche Holding AG reported positive results reported from ...
2023-05-17 05:06:24 ET Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) said its oral drug fenebrutinib met the main and secondary goals of a phase 2 trial by reducing brain lesions in adults with relapsing forms of multiple sclerosis (RMS). The 12-week mid-stage study, dubbed FENopta...
2023-05-16 01:29:25 ET Summary GSK's operating income margin in Q1 2023 was 29.35%, showing an increase in the previous quarter and the last year. Vaccine sales were $2,493 million in Q1 2023, up 11.9% year-over-year, mainly due to Fluarix and FluLaval, which regulators approved t...
The 16-year renewable energy contract is for the Liberty County Solar project in Texas and is expected to be operational in 2024, propelling Merck KGaA, Darmstadt, Germany, to 90% purchased renewable electricity in the U.S. TEMPE, AZ / ACCESSWIRE / May 15, 2023 / EMD Electronics, the U.S. an...
2023-05-11 13:41:03 ET Merck KGaA (MKGAF) Q1 2023 Earnings Conference Call May 11, 2023 08:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - Chair of the Executive Board and Chief Executive Officer Marcus Kuhnert - Chi...
2023-05-11 06:30:43 ET Merck KGaA press release ( OTCPK:MKGAF ): Q1 Revenue of €5.3B (+1.9% Y/Y) misses by $470M . EBITDA -2.6% to € 1.6B For further details see: Merck KGaA reports Q1 results
2023-04-26 13:15:56 ET Summary Initiation of phase 3 study using PDS0101 in combination with Keytruda for the treatment of patients with unresectable, recurrent/metastatic Human Papillomavirus positive head and neck cancer expected Q4 of 2023. It is said that the global head and n...
2023-04-18 11:30:00 ET Summary Merck KGaA (not to be confused with the US-based Merck) is a German company in the life sciences and healthcare sector. The balance sheet is looking very healthy again focusing on the reduction of the net debt. This means Merck is in a position a...
Agreement with the Commonwealth of Pennsylvania supports the expansion of manufacturing capacities for the semiconductor industry. The roughly $300 million investment is part of the company's 'Level Up' program aimed at accelerating its innovation and capacities. HOMETOWN, PA / ACCESSWIRE / A...
2023-04-12 05:11:22 ET Merck KGaA ( OTCPK:MKGAF ) ( OTCPK:MKKGY ) said the U.S. Food and Drug Administration (FDA) placed a partial clinical hold on starting new patients on its multiple sclerosis therapy evobrutinib in the U.S. The German company's shares trading ...
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...